HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 11, November 2019 – Evaluating cost effectiveness of genomic profiling       » Ion treatment offers new hope for cancer patients       » Empowering sustainability through innovation       » Meeting clinical needs in Asia with HealthTech       » The key in diagnosis and treatment       » Singapore's first private co-working laboratory and office space       » Singapore-based MedTech company announced as winner of 2019 Asia Pacific Showcase Competition at The MedTech Forum      
EDITOR'S LETTER
 

The seven among the top ten selling drugs in 2013 and 2014 worldwide are bio-therapeutics represented by antibody drugs. This continues to be expected due to their prominent clinical effects. They can block protein-protein interaction efficiently and specifically, which is generally hard to achieve with conventional small molecule drugs.

Smaller antibody formats are gaining more and more interest because of their higher tissue penetration, lower cost, and higher ability to sweep antigen (higher mol/mg ratio). However, there are various obstacles in the course of antibody drug discovery [1]. The topic of this month covers the basic technologies developed by academia in Japan. They are expected to eliminate the obstacles of current antibody drug discovery, and to promote related research area.

A fundamental problem is the difficulty in obtaining lead antibodies against membrane proteins. Hamakubo et al. have developed a method to display membrane proteins on a viral envelope for antigen immunization. Another problem is the difficulty in lead antibody optimization. Lead antibodies should be optimized in multiple aspects including higher affinity, better biological activity, longer PK, better stability, lower aggregation, higher expression, lower viscosity, etc. Although in silico optimization methods including our work [2] have been reported, more powerful algorithms are necessary. Tsuchiya and Mizuguchi have carried out informatics research on known antibody structures. They found some rules of antibody-antigen interactions. Those rules would be good hints for optimization.

Higher concentration antibody solutions are necessary for the switch from intravenous to self-injecting subcutaneous administration. Krayukhina and Uchiyama overviewed antibody solution viscosity and intermolecular interactions. They also highlighted the importance of taking the packaging material into consideration. Smaller antibody formats are expected to penetrate well to reach antigens that are normally hard to be reached by normal antibody in patients. A typical small antibody format is single chain variable fragment (scFv). It is a single polypeptide composed of heavy chain and light chain in variable domain connected by a linker. However, this modality is usually unstable. To combat this, Hoshino et al. developed a method to enhance stability of a scFv with amino acid substitutions by using a super-computer. VHH antibody is another example of small antibody. It is the variable domain of camelid heavy-chain antibody. Akazawa-Ogawa and Hagihara could enhance the thermal stability on VHH antibodies. Ito鈥檚 group used VHH and carried out high-throughput sequencing on next generation sequencer to identify specific VHH binders from the phage library.

References:

  1. Shirai H, Prades C, Vita R, et al. Antibody informatics for drug discovery. Biochim Biophys Acta 2014; 1844:2002-2015.
  2. Kiyoshi M, Caaveiro JM, Miura E, et al. Affinity improvement of a therapeutic antibody by structure-based computational design: generation of electrostatic interactions in the transition state stabilizes the antibody-antigen complex. PloS One 2014; 9:e87099
Hiroki Shirai, PhD, executive fellow, Bioscience Research Laboratories, Astellas Pharma Inc.
Guest Editor for APBN August issue 2016

Click here for the complete issue.

NEWS CRUNCH  
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy